Edwards Lifesciences (EW) News Today $73.31 -1.51 (-2.02%) Closing price 06/17/2025 03:59 PM EasternExtended Trading$73.06 -0.25 (-0.34%) As of 05:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period QRG Capital Management Inc. Acquires 5,992 Shares of Edwards Lifesciences Corporation (NYSE:EW)QRG Capital Management Inc. lifted its holdings in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 7.8% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 83,294 shares of the medical research company's stock after pJune 18 at 4:24 AM | marketbeat.comBirch Hill Investment Advisors LLC Grows Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Birch Hill Investment Advisors LLC grew its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 756,599 shares of the medical research company's stock afterJune 17 at 7:34 AM | marketbeat.comPKO Investment Management Joint Stock Co Has $1.23 Million Position in Edwards Lifesciences Co. (NYSE:EW)PKO Investment Management Joint Stock Co grew its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 112.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,000 shares of the medical research companJune 17 at 7:05 AM | marketbeat.comWD Rutherford LLC Has $339,000 Stake in Edwards Lifesciences Co. (NYSE:EW)WD Rutherford LLC reduced its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 49.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,785 shares of the medical research company's stock afterJune 17 at 5:29 AM | marketbeat.comInscription Capital LLC Makes New Investment in Edwards Lifesciences Co. (NYSE:EW)Inscription Capital LLC acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 24,000 shares of the medical research company's stock, valued at approximatelyJune 17 at 5:29 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Insider Larry L. Wood Sells 8,950 SharesJune 17 at 4:32 AM | insidertrades.comBank Pictet & Cie Europe AG Lowers Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Bank Pictet & Cie Europe AG trimmed its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 42.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,902 shares of the medical research company's stock afJune 17 at 4:08 AM | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) Insider Sells 8,950 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) insider Larry L. Wood sold 8,950 shares of Edwards Lifesciences stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $75.23, for a total value of $673,308.50. Following the transaction, the insider now directly owns 206,900 shares in the company, valued at approximately $15,565,087. The trade was a 4.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.June 16 at 6:17 PM | marketbeat.comMason & Associates Inc Sells 4,080 Shares of Edwards Lifesciences Co. (NYSE:EW)Mason & Associates Inc trimmed its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 57.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,982 shares of the medical research coJune 16 at 7:36 AM | marketbeat.comFarther Finance Advisors LLC Buys 7,013 Shares of Edwards Lifesciences Co. (NYSE:EW)Farther Finance Advisors LLC lifted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 390.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 8,808 shares of the medical research company's stock after acquiring an additional 7,013 shareJune 15 at 3:49 AM | marketbeat.comUnion Bancaire Privee UBP SA Sells 8,180 Shares of Edwards Lifesciences Co. (NYSE:EW)Union Bancaire Privee UBP SA decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 55.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,622 shares of the medical reseaJune 14, 2025 | marketbeat.comSmithbridge Asset Management Inc. DE Takes $1.03 Million Position in Edwards Lifesciences Co. (NYSE:EW)Smithbridge Asset Management Inc. DE bought a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,266 shares of the medical research company's stock, valJune 13, 2025 | marketbeat.comTobam Has $3.17 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Tobam reduced its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 26.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 43,737 shares of the medical research company's stock after selling 15,557 shares during the quarter.June 13, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Handelsbanken Fonder ABHandelsbanken Fonder AB trimmed its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 54.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 224,410 shares of the medical research company's stock after sellinJune 12, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,107,657 shares of the medical research company's stock afJune 11, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Receives $80.20 Average Price Target from AnalystsJune 11, 2025 | americanbankingnews.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Manitou Investment Management Ltd.Manitou Investment Management Ltd. lifted its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 5.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 189,656 shares of the medical research company's stoJune 10, 2025 | marketbeat.comMerit Financial Group LLC Acquires 5,212 Shares of Edwards Lifesciences Co. (NYSE:EW)Merit Financial Group LLC raised its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 93.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,793 shares of the medical research company's stock after buying an adJune 9, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Seilern Investment Management LtdSeilern Investment Management Ltd cut its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 7.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,369,459 shares of the medical research company's stock afterJune 8, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Receives Consensus Recommendation of "Hold" from BrokeragesEdwards Lifesciences Co. (NYSE:EW - Get Free Report) has been given an average recommendation of "Hold" by the twenty-five research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, thirteen have given a hold ratingJune 8, 2025 | marketbeat.com3,426 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Unique Wealth LLCUnique Wealth LLC purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,426 shares of the medical research company's stJune 7, 2025 | marketbeat.comRetireful LLC Buys New Holdings in Edwards Lifesciences Co. (NYSE:EW)Retireful LLC purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 5,459 shares of the medical research company's stock, valueJune 5, 2025 | marketbeat.comArthur M. Cohen & Associates LLC Sells 4,295 Shares of Edwards Lifesciences Co. (NYSE:EW)Arthur M. Cohen & Associates LLC trimmed its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 22.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,163 shares of the medical research company'June 5, 2025 | marketbeat.comEdwards Lifesciences (NYSE:EW) Rating Increased to Hold at Dbs BankDbs Bank raised Edwards Lifesciences to a "hold" rating in a report on Monday.June 5, 2025 | marketbeat.comGAMMA Investing LLC Increases Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)GAMMA Investing LLC boosted its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 7,061.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 340,946 shares of the medical research company's stock after purchasing an additional 336,185 shJune 5, 2025 | marketbeat.comEdwards Lifesciences: With A Heart Beating Strong And SteadyJune 4, 2025 | seekingalpha.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 2,570 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Donald E. Bobo, Jr. sold 2,570 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $77.40, for a total transaction of $198,918.00. Following the transaction, the vice president now owns 50,356 shares in the company, valued at approximately $3,897,554.40. The trade was a 4.86% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.June 3, 2025 | marketbeat.comOrser Capital Management LLC Invests $2.10 Million in Edwards Lifesciences Co. (NYSE:EW)Orser Capital Management LLC purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 28,982 shares of the medical reJune 3, 2025 | marketbeat.comBaxter Bros Inc. Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW)Baxter Bros Inc. trimmed its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 12.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 77,236 shares of the medical research compJune 3, 2025 | marketbeat.comCzech National Bank Buys 7,587 Shares of Edwards Lifesciences Co. (NYSE:EW)Czech National Bank boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 5.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,468 shares of the medical reJune 3, 2025 | marketbeat.comRhumbline Advisers Has $81.91 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Rhumbline Advisers raised its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,130,154 shares of the medical research compaJune 3, 2025 | marketbeat.comDonald E. Bobo, Jr. Sells 2,570 Shares of Edwards Lifesciences Co. (NYSE:EW) StockJune 3, 2025 | insidertrades.comHarbor Investment Advisory LLC Buys 4,682 Shares of Edwards Lifesciences Co. (NYSE:EW)Harbor Investment Advisory LLC lifted its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 26.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,507 shares of the medical research company's stock aJune 2, 2025 | marketbeat.comLeerink Partnrs Has Positive Estimate for EW Q3 EarningsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Investment analysts at Leerink Partnrs boosted their Q3 2025 earnings per share (EPS) estimates for Edwards Lifesciences in a research note issued on Thursday, May 29th. Leerink Partnrs analyst M. Kratky now expects that the medical research compJune 2, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Fulcrum Capital LLCFulcrum Capital LLC boosted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 126,267 shares of the medical research company's stock after acquirinJune 1, 2025 | marketbeat.comParallel Advisors LLC Reduces Stake in Edwards Lifesciences Co. (NYSE:EW)Parallel Advisors LLC cut its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 11.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 58,569 shares of the medical research company's stock after selling 7,229 shares during theJune 1, 2025 | marketbeat.comBath Savings Trust Co Sells 8,442 Shares of Edwards Lifesciences Co. (NYSE:EW)Bath Savings Trust Co lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 42.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,535 shares of the medical research company's stock afterMay 31, 2025 | marketbeat.comEdwards Lifesciences: Overbought Given Current Growth ProspectsMay 30, 2025 | seekingalpha.comBoston Common Asset Management LLC Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW)Boston Common Asset Management LLC lessened its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 11.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 135,312 shares of the medical research companMay 30, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Legacy Wealth Management LLC MSLegacy Wealth Management LLC MS decreased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 78.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,045 shares of the medical research company's stock afterMay 30, 2025 | marketbeat.comPKO Investment Management Joint Stock Co Makes New Investment in Edwards Lifesciences Co. (NYSE:EW)PKO Investment Management Joint Stock Co acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,000 shares of the medicMay 30, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Holdings Cut by Siemens Fonds Invest GmbHSiemens Fonds Invest GmbH lowered its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 54.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,242 shares of the medical research company's stock aftMay 30, 2025 | marketbeat.comGTS Securities LLC Lowers Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)GTS Securities LLC cut its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 73.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,743 shares of the medical research company's stock after selling 1May 30, 2025 | marketbeat.comFairtree Asset Management Pty Ltd Takes $1.08 Million Position in Edwards Lifesciences Co. (NYSE:EW)Fairtree Asset Management Pty Ltd bought a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 14,541 shares of the medical research company's stock, valued at approximatelMay 29, 2025 | marketbeat.comProbity Advisors Inc. Acquires New Holdings in Edwards Lifesciences Co. (NYSE:EW)Probity Advisors Inc. acquired a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,981 shares of the medical research company's stock, valued at approximately $295,000. Other institMay 29, 2025 | marketbeat.comMackenzie Financial Corp Buys 23,729 Shares of Edwards Lifesciences Co. (NYSE:EW)Mackenzie Financial Corp lifted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 22.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 129,845 shares of the medical research company's stock after acquiring an additional 23,729 sharesMay 29, 2025 | marketbeat.comToronto Dominion Bank Raises Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Toronto Dominion Bank lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 5.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 317,326 shares of the medical research company's stock after acqMay 29, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Buys Shares of 1,251,259 Edwards Lifesciences Co. (NYSE:EW)Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,251,259 shares of the medicMay 28, 2025 | marketbeat.comHeck Capital Advisors LLC Makes New Investment in Edwards Lifesciences Co. (NYSE:EW)Heck Capital Advisors LLC acquired a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,179 shares of the medical research company's stock, valued at approximMay 28, 2025 | marketbeat.comWoodline Partners LP Has $773,000 Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Woodline Partners LP cut its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 97.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,441 shares of the medical research company's stock after sellinMay 28, 2025 | marketbeat.com Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼1.380.56▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼1625▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Boston Scientific News Stryker News Medtronic News Becton, Dickinson and Company News IDEXX Laboratories News ResMed News DexCom News STERIS News Insulet News Baxter International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EW Stock Free EW Stock Alerts